Please do not leave this page until complete. This can take a few moments.
More than one-third of all venture capital money invested in biopharmaceutical companies last year went to Massachusetts companies, with the bulk of those dollars headed to companies in Cambridge and nearby, according to a new industry report.
The Massachusetts Biotechnology Council on Wednesday released its annual Industry Snapshot, which tallied a total of $3.1 billion in venture investments in biopharma companies here in 2017, and another $2.7 billion raised by Massachusetts biopharma companies in the first half of 2018.
Cambridge-based companies received 62 percent, or $1.8 billion, of all biotech venture investment in the state, with companies in Boston ($320 million), Waltham ($242 million), Lexington ($129 million) and Woburn ($97 million) accounting for a significant portion of the rest, the report said.
"Massachusetts biopharmas continue to lead the industry in tackling the toughest unmet medical needs, creating a new wave of breakthrough therapies that treat the underlying cause of disease, not just the symptoms, and some that people are even calling cures," MassBIO President and CEO Robert Coughlin said. "Cumulatively, it's creating unbelievable opportunities to change the course of disease and improve the lives of patients, and investors want to be a part of this."
Massachusetts companies accounted for 48 percent of all initial public offerings by U.S.-based biotech companies in 2017, the report said, and the 15 Massachusetts IPOs so far in 2017 account for nearly 40 percent of all U.S.-based biotech IPOs.
The 12 companies that went public in 2016 were concentrated geographically in a similar way as the venture investments, with six located in Cambridge, three in Waltham and one each in Boston, Newton and Burlington.
Jobs in the biopharma industry have increased by 28 percent over the past 10 years, according to MassBIO, hitting 69,941 in 2017 from the 54,280 recorded in 2008.
Those nearly 70,000 workers earned an average annual wage of $145,731.
Sanofi's 4,800 employees make it the Bay State's largest biopharma employer, followed by Shire, with 3,050 workers and Biogen with 2,443. The same trio topped the list last year.
Stay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Sign upWorcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
SubscribeWorcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
See Digital EditionStay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Worcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
Worcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy
0 Comments